Moral Conflict Within A Lethal Prescription: The Trouble with Zorlite, by Julian Friedland, Ph.D

708 Words2 Pages

A Lethal Prescription The Trouble with Zorlite, by Julian Friedland, Ph.D., is an excellent case study to illustrate and assess moral conflict. The case describes a situation where the U.S. Food and Drug Administration (FDA) failed to appropriately protect individuals by approving Zorlite, a prescription drug for intestinal irregularly, shown to increase heart attack risk by a multiple of 5. Tom Green, a reviewer with the FDA was so troubled, he conducted his own large study that concluded higher doses of Zorlite significantly increase the risk of heart attack. Green inferred that due to the fairly common occurrence of heart attacks and Zorlite’s broad application, that approval could result in the death or harm of tens of thousands. However, the FDA approved Zorlite over Green’s objections, citing his findings as scientific rumor.

By approving Zorlite, the FDA failed to act morally as defined by deontology. Sometimes describe as “duty” or “rule” based, deontological ethics posits that one’s duty is to do what is morally right and to avoid what is morally wrong, regardless of consequences. Immanuel Kant, who I will describe in more detail later, argued that it is not consequences, but motives that make an act right or wrong. When applying this philosophy to the FDA’s decision to approve Zorlite, it is apparent that the decision was amoral. The FDA failed to meet its obligation to protect the lives and health of individuals above all else by deriving its motivations from the pursuit of budget expansion and expediency. This evaluation is sustained when we learn that the manufacturer, in response to numerous lawsuits, removed Zorlite from the market.

Contemporary deontological ethical theory received its formulation in the writin...

... middle of paper ...

...ine and are allowing external events to dictate outcomes. Rational being’s free will, and by extension freedom, is subverted in this case.

Deontology dictates that the FDA has a moral obligation to protect the health and well being of individuals above all else. Those individuals are to be seen as ends, not merely means, and that are allowed to be self-determinate in their actions. Regardless of consequences, individuals at the FDA have a duty to do what is morally right. To this end, PADUFA should be repealed; the FDA should revert back to public funding, and a review of the approval process just undertaken. Leaders should incorporate this maxim into the mission of the agency and work to instill a culture of morality. Going forward, a more stringent approval process should be instilled with rigorous testing. Public safety must be the singular goal of the agency.

Open Document